Fisher & Paykel Healthcare Corporation Limited (FSPKF)
OTCMKTS · Delayed Price · Currency is USD
23.00
0.00 (0.00%)
Dec 16, 2025, 9:30 AM EST
FSPKF Market Cap
FSPKF has a market cap or net worth of $12.65 billion as of December 17, 2025. Its market cap has decreased by -4.46% in one year.
Market Cap
12.65B
Enterprise Value
12.56B
Revenue
1.25B
Ranking
n/a
PE Ratio
49.93
Stock Price
$23.00
Market Cap Chart
Since February 28, 1992, FSPKF's market cap has increased from 130.80M to 12.65B, an increase of 9,572.00%. That is a compound annual growth rate of 14.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 17, 2025 | 12.65B | 0.36% |
| Dec 31, 2024 | 12.61B | 44.45% |
| Dec 29, 2023 | 8.73B | 5.18% |
| Dec 30, 2022 | 8.30B | -35.87% |
| Dec 31, 2021 | 12.94B | -5.34% |
| Dec 31, 2020 | 13.67B | 58.98% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 849.79M |
| Glass House Brands | 789.81M |
| Elite Pharmaceuticals | 537.07M |
| CytoDyn | 398.68M |
| Northwest Biotherapeutics | 396.23M |
| American Oncology Network | 365.47M |
| Silence Therapeutics | 296.16M |
| Nika Pharmaceuticals | 291.10M |